Display Settings:

Format

Send to:

Choose Destination
    Cell Mol Life Sci. 2007 Sep;64(18):2358-77.

    Role of heregulin in human cancer.

    Source

    Novartis Institutes for Biomedical Research (NIBR), Oncology, WKL-125.12.59, Klybeckstrasse 141, 4002, Basel, Switzerland. madlaina.breuleux@novartis.com

    Abstract

    Heregulin (HRG) is a soluble secreted growth factor, which, upon binding and activation of ErbB3 and ErbB4 transmembrane receptor tyrosine kinases, is involved in cell proliferation, invasion, survival and differentiation of normal and malignant tissues. The HRG gene family consists of four members: HRG-1, HRG-2, HRG-3 and HRG-4, of which a multitude of different isoforms are synthesized by alternative exon splicing, showing various tissue distribution and biological activities. Disruption of the physiological balance between HRG ligands and their ErbB receptors is implicated in the formation of a variety of human cancers. The general mechanisms involved in HRG-induced tumorigenesis is discussed.

    PMID:
    17530167
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk